Pregled bibliografske jedinice broj: 196428
Murine myeloid leukemia: in vivo suppression by sericystatin A, a proteinase inhibitor from leukocytes
Murine myeloid leukemia: in vivo suppression by sericystatin A, a proteinase inhibitor from leukocytes // European journal of cancer & clinical oncology, 19 (1983), 1; 123-126 doi:10.1016/0277-5379(83)90406-6 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 196428 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Murine myeloid leukemia: in vivo suppression by sericystatin A, a proteinase inhibitor from leukocytes
Autori
Pavelić, Krešimir ; Sirotković, Maja ; Kopitar, Marija ; Pavelić, Jasminka ; Vuk-Pavlović, Stanimir
Izvornik
European journal of cancer & clinical oncology (0277-5379) 19
(1983), 1;
123-126
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
murine myeloid leukemia ; sericistatin A
Sažetak
Parenteral administration of sericystatin A, an intracellular leukocyte inhibitor of the proinsulin-splitting enzyme cathepsin B, prolongs the mean survival time of mice with insulin-dependent myeloid leukemia. Sericystatin A reduces the supranormal blood levels of substances detectable by insulin-specific radioimmunoassay in these animals ; this effect is abolished by concomitant insulin administration. It is concluded that sericystatin A reduces tumor proliferation indirectly, i.e. by reducing circulating insulin levels.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Imunološki zavod d.d.,
Institut "Ruđer Bošković", Zagreb
Profili:
Krešimir Pavelić
(autor)
Maja Sirotković-Skerlev
(autor)
Jasminka Pavelić
(autor)
Stanimir Vuk-Pavlović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Excerpta Medica
- Index Medicus
